ADMINISTRATION DE NRF2 EN TANT QUE THÉRAPIE DE PROTECTION CONTRE LES DÉRIVÉS RÉACTIFS DE L'OXYGÈNE

• 收藏
• 分享

专利权人:

University of Florida Research Foundation; Inc.

发明人:

申请号：

EP15752059.4

公开号：

EP3107939A4

申请日:

2015.02.19

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

The present invention provides methods and compositions for treating and/or preventing age related macular degeneration and other conditions involving macular degeneration, ocular neovascularization, or inflammation, including ocular inflammation. In some embodiments, the methods comprise administering an expression vector that delivers a secretable and cell penetrating Nrf2 to a subject in need thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/